DiNuzzo Private Wealth’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6
Closed -$172 1460
2024
Q2
$172 Buy
6
+1
+20% +$28 ﹤0.01% 1287
2024
Q1
$147 Hold
5
﹤0.01% 1246
2023
Q4
$169 Buy
+5
New +$146 ﹤0.01% 1247

Other funds holding PCRX

DiNuzzo Private Wealth's PCRX Position: Q3 2024 in Review

DiNuzzo Private Wealth sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 6 shares — an estimated $172 sold.

DiNuzzo Private Wealth first reported a position in PCRX in Q4 2023 and held it in 3 quarters. The position peaked at $172 in Q2 2024. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • DiNuzzo Private Wealth reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • DiNuzzo Private Wealth sold 6 Pacira BioSciences shares in Q3 2024, an estimated $172.
  • DiNuzzo Private Wealth first reported a position in Pacira BioSciences in Q4 2023 and held it in 3 quarters.
  • DiNuzzo Private Wealth's Pacira BioSciences position peaked at $172 in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2024, filed 17 Oct 2024.